XTNT logo

XTANT MEDICAL HOLDINGS INC

XTNTNYSE AMERICAN
πŸ† #3158 by market capUS Equity
$0.33β–Ό $0.09 (βˆ’26.39%)
Live
1hβ€”
24hβ–Ό 26.4%
7dβ–Ό 26.4%
14dβ–Ό 23.2%
30dβ–Ό 22.6%
1yβ–Ό 47.3%
🏦Market Cap
$46M
Small Cap
πŸ“ˆRevenue Growth (YoY)
-0.3%
Declining
πŸ“ŠGross Margin
62.3%
High
πŸ’΅FCF Margin
8.3%
Moderate
βš–οΈP/S Ratio
0.5x
Cheap
Otter Score
48
Weak

Trading Snapshot

Day Range
$0.32 – $0.33
52-Week Range
$0.39 – $0.95
Volume
$3.36B
Avg Volume
$2.64B
Shares Outstanding
140.3M
Next Earnings
Oct 16, 2026

Fundamentals Snapshot

Annual Revenue
$119M
Last Q Revenue
$33M
P/E Ratio
34.1
P/S Ratio
0.5x
EPS (TTM)
$0.01
Dividend Yield
β€”

Why Investors Own XTNT

  • βœ“High-growth profile β€” revenue up +38.5% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 26% gross margin and 4% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$119Mβ–² +34.9% YoY
Gross Margin (TTM)
26.0%β–² +3.6% YoY
Operating Income (TTM)
$15Mβ–² +34.9% YoY
Free Cash Flow (TTM)
$5Mβ–² +34.9% YoY

About XTANT MEDICAL HOLDINGS INC

A company profile for XTANT MEDICAL HOLDINGS INC isn’t available yet β€” check back soon.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
48/100

Analyst Price Target

β“˜
Average Target
$0.41
β–² +25.6% Upside
High Target$0.49
Low Target$0.37
Based on 13 analysts

Latest News & Updates